Ask About Adherence: 3 factors impacting medication adherence for patients with diabetes and how our proactive affordability solutions can help
By Emilie Signora | July 20, 2021
Earlier this year, PhRMA released a proactive agenda with common-sense, patient-centered reforms to improve access to quality, affordable health care. The urgency of building a stronger, more...
Read More
New reports shed light on key facts about medicines and affordability
By Brian Newell | June 8, 2021
A recently released report by IQVIA – an independent organization specializing in health care research – provides new data showing prices for brand medicines went down last year. The report offers...
Read More
Out-of-pocket trends in Medicare Part D show rising costs for seniors
By Katie Koziara | May 24, 2021
A new study based on IQVIA data shows alarming trends in rising out-of-pocket costs for brand medicines among Medicare Part D beneficiaries with serious and complex conditions like cancer, HIV and...
Read More
Study finds nearly half of payers believe innovative contracts can lead to lower patient out-of-pocket costs
By Katie Koziara | May 17, 2021
According to a recent survey by Verpora that will be presented this week at ISPOR, nearly half of U.S. payers surveyed expressed a belief that wider implementation of innovative contracts could...
Read More
New data from insurers show detriments of copay accumulator adjustment programs
By Katie Koziara | April 28, 2021
Commercial health insurers are starting to admit what the biopharmaceutical research industry has been warning for some time: copay accumulator adjustment programs hurt patient outcomes and shift...
Read More
West Virginia becomes the first state to lower patient costs by sharing the savings
By Scott LaGanga | April 20, 2021
In a historic moment for patient affordability, last week West Virginia became the first state in the nation to adopt ground-breaking legislation, HB2263, requiring insurers and their PBMs to...
Read More
Nearly 40% of commercially insured patients face half their annual out-of-pocket expenses from just one health care encounter
By Katie Koziara | March 2, 2021
A new study published in Health Affairs finds that for nearly 40% of commercially insured patients, half of their annual out-of-pocket expenses for medical treatments come from just one hospital,...
Read More
Top five issues voters want addressed in the administration’s first 100 days
By Mark Keida | February 18, 2021
When voters cast their ballots in the 2020 election, they made clear their focus on getting COVID-19 under control and fixing the economy. However, health care was still important to many voters,...
Read More
Insurers shift medicine costs to patients with severe chronic illnesses
By Gabby Migliara | February 1, 2021
For many patients with complex and chronic conditions, high out-of-pocket costs for medicines pose a significant challenge. Recent research revealed a broken insurance system that fails to help...
Read More
The latest misleading “poll” on drug pricing
By Brian Newell | January 28, 2021
When a front group for insurers and drug cost middlemen promote a poll on drug pricing, everyone’s immediate reaction should include a healthy dose of skepticism. The same is true for a poll from...
Read More
Medicare Monday (100)
340B Spotlight (46)
Cost & Consequence (0)
